BPC-157
BPCPentadecapeptide central to tissue-repair research.
Also known as: Body Protection Compound-157, Pentadecapeptide BPC 157
Overview
BPC-157 is a synthetic pentadecapeptide derived from a protein in gastric juice. It is one of the most widely studied compounds in tissue-repair, angiogenesis, and connective-tissue research.
One of the most-studied repair peptides in preclinical literature, with rodent models reporting accelerated tendon, ligament, muscle, and gut-mucosa healing, enhanced angiogenesis, and cytoprotection. Notably stable in gastric acid relative to most peptides. Human clinical data remain limited.
Studied for promoting angiogenesis and cell migration, upregulating growth-factor receptors, and modulating the nitric-oxide pathway in repair models.
Molecular information
Gly-Glu-Pro-Pro-Pro-Gly-Lys-Pro-Ala-Asp-Asp-Ala-Gly-Leu-ValDerived from a protective protein fragment found in human gastric juice.
Pharmacokinetics
Illustrative relative-concentration model derived from published pharmacokinetic research. Curve is normalized and provided for educational comparison only — not a dosing schedule.
Research applications
- Tendon, ligament, and muscle repair research
- Angiogenesis and vascular-formation studies
- Gastrointestinal-protection investigations
Research protocols
Protocols summarized from published research models. Provided for scientific reference only — not dosing guidance for human use.
Observed effects timeline
Aggregated observations reported across research literature. Timing and magnitude vary by model and are not a guarantee of outcome.
Day 1–7
Early reduction of inflammatory signaling and onset of repair processes reported in models.
Week 2–4
Accelerated connective-tissue repair and angiogenesis reported in preclinical research.
Week 4–6
Continued tissue remodeling reported; effects taper after discontinuation.
Research compatibility
Describes how compounds are studied alongside one another in the literature. Not a recommendation to co-administer.
TB-500
Frequently co-studied together as a tissue-repair stack.
GHK-Cu
Complementary repair/remodeling pathways in research.
KPV
Anti-inflammatory co-study designs.
GLP-3
Distinct pathways; no documented interference.
CJC-1295 / Ipamorelin
BPC-157 increases GH receptor expression, amplifying CJC-1295/Ipa GH benefits.
AOD-9604
Safe combination - BPC-157 promotes tissue repair via growth factors, AOD-9604 targets fat metabolism via beta-3 adrenergic receptors. No pathway overlap. Often combined in regenerative protocols.
How to reconstitute
Reconstitute with bacteriostatic water, swirl gently, and refrigerate. Do not shake — agitation can degrade the peptide.
- 1Allow the vial to reach room temperature (15–20 minutes).
- 2Swab the stopper with alcohol and let it air dry.
- 3Add bacteriostatic water slowly down the vial wall.
- 4Swirl gently until fully dissolved into a clear solution.
- 5Refrigerate at 2–8 °C and protect from light.
Quality indicators
Uniform white powder
Lyophilized cake should be white to off-white with no discoloration.
Clear solution
Reconstitutes to a clear, colorless, particle-free solution.
Acid stability
BPC-157 is unusually stable in gastric environments versus most peptides.
Slight clumping
Small clumps that dissolve completely with gentle swirling are acceptable — shipping can cause minor compaction.
Collapsed or melted appearance
Powder that looks collapsed, melted, or stuck to the vial walls may have been exposed to heat in transit.
Cloudy after reconstitution
Persistent cloudiness, particles, or precipitate after gentle mixing can indicate a degraded or contaminated peptide.
Reported observations & safety
Safety signals reported in the research literature. Compiled for scientific awareness — not medical advice.
- Generally well tolerated in rodent studies; human safety data are limited.
- Mild injection-site reactions are the most commonly reported signal.
- Long-term human safety has not been established in controlled trials.
References & further reading
Stable gastric pentadecapeptide BPC 157 in tissue healing (review)
Comprehensive review of BPC-157 repair, cytoprotective, and angiogenic effects across rodent injury models.
View studyBPC 157 and tendon-to-bone healing (preclinical)
Study reporting accelerated tendon healing and improved functional outcomes following BPC-157 administration.
Topics
This entry is provided for educational and informational purposes only. It is not medical advice, a dosing protocol, or a claim of therapeutic benefit. Research compounds are supplied strictly for laboratory and research use — not for human or veterinary consumption.
Large body of preclinical and clinical literature.
BPC-157 is stocked as a research-grade compound, ≥99% by HPLC, third-party verified.
View in catalogue